Par Drugs & Chemicals Ltd

NSE: PAR · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹131.41
Market cap: ₹161.7 Cr
Revenue (annual): ₹103.7 Cr
Net profit (annual): ₹13.11 Cr
P/E (TTM): 11.2×Sector 50.4×
Promoter holding: 73.41%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 Sep 2026 13:27 IST NSE

Management Change

Par Drugs & Chemicals Management Change

Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.

Read the filing ↗